Fortress Biotech (FBIO) Retained Earnings (2010 - 2026)

Fortress Biotech's Retained Earnings history runs 16 years deep, the most recent figure standing at $783.9 million for Q4 2025.

• In Q4 2025, Retained Earnings rose 205.81% year-over-year to $783.9 million; the TTM figure through Dec 2025 stood at $783.9 million (up 205.81% YoY), while the FY2025 annual figure was $783.9 million, up 205.81% from the prior year.
• Retained Earnings for Q4 2025 stood at $783.9 million, up from -$730.1 million in the prior quarter.
• The five-year high for Retained Earnings was $783.9 million in Q4 2025, with the low at -$740.9 million in Q4 2024.
• The 5-year median for Retained Earnings is -$555.3 million (2021), against an average of -$211.4 million.
• The sharpest annual moves came in 2023 and 2025: Retained Earnings surged 223.12% in 2023, then sank 199.58% in 2025.
• Fortress Biotech's Retained Earnings stood at -$547.5 million in 2021, then slipped by 15.85% to -$634.2 million in 2022, then retreated by 9.56% to -$694.9 million in 2023, then declined by 6.62% to -$740.9 million in 2024, then surged by 205.81% to $783.9 million in 2025.
• Business Quant data shows FBIO's Retained Earnings at $783.9 million in Q4 2025, -$730.1 million in Q3 2025, and -$736.0 million in Q2 2025.